Buradasınız

Anasayfa » Content

Göğüs Hastalıkları Kliniğinde Mortalite Nedenleri

The Causes of Mortality in the Department of Pulmonary Diseases

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2010

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
A retrospective study was performed to investigate the mortality among the patients hospitalized in department of chest diseases Dicle University medical school clinic. The patients passed out in this clinic in the period from January 2004 to May 2009 were evaluated. It was determined that totally 4417 patients were hospitalized (8892 hospitalization) in this period and 384 (8.6%) of them resulted in death. The mean age of the patients was 66.8±15.3 and 92 (33%) were women and 187 (67%) were men. The principal causes of their mortality were pneumonia in 92 patients (33.1%), chronic obstructive pulmonary disease (COPD) in 87 (31.2%) patients, pulmonary cancer in 52 (18.6%) patients, tuberculosis (TB) in 18 (6.5%) patients, pulmonary thromboembolism (PE) in 18 (6.5%) patients and another diseases in 12 (4,2%). When the accompanying diseases were evaluated, no additional diseases were determined in 130 (46.6%) patients; 41 patients (14.7%) had cardiac disorders, 22 patients (7.9%) had cancers outside the lungs, 18 patients (6.5%) had cor pulmonale, 17 patients (6.1%) had neurologic disorders, 15 patients (5.4%) had renal diseases, 10 patients (3.6%) had diabetes mellitus (DM), 9 patients (3.1%) had TB and 17 patients (6.1) had unclassified disorders. In conclusion, we think that the knowledge about their mortality rates and the causes of mortality is useful for every clinic for their approach to the patients and considering the accompanying diseases is helpful to decrease the mortality
Bookmark/Search this post with
Abstract (Original Language): 
Dicle Üniversitesi Tıp Fakültesi Göğüs hastalıkları kliniğinde yatırılarak tedavi edilen hastalarda mortalite sıklığını ve nedenlerini araştırmak amacıyla retrospektif bir çalışma planlandı. Ocak 2004-Mayıs 2009 arasında bu klinikte yaşamını yitiren hastalar değerlendirildi. Bu süre içerisinde toplam 4417 hastanın yatırıldığı, (8892 yatış) bunların 384 ünün (%8.6) öldüğü saptandı. Yaş ortalaması 66.8±15.3 olan hastalardan 92’si (%33) bayan, 187’si (%67) erkekti. Ana ölüm nedenleri incelendiğinde, 92 hasta (% 33.1) pnömoni, 87 hasta (%31.2) kronik obstrüktif akciğer hastalığı (KOAH), 52 hasta (%18.6) akciğer kanseri, 18 hasta (%6.5) tüberküloz (TB) ,18 hasta (% 6.5) pulmoner tromboemboli ve 12 hasta (%4.2) diğer nedenlerle ölmüştü. Eşlik eden hastalıklar incelendiğinde 130 hastanın (%46.6) ek hastalığı olmadığı, 41 hasta (%14.7) kardiyak hastalıklar, 22 hasta (%7.9) akciğer dışı kanserler, 18 hasta (%6.5) kor pulmonale, 17 hasta (%6.1) nörolojik hastalıklar,15 hasta (%5.4) böbrek hastalıkları, 10 hasta (%3.6) diabetes mellutus DM, 9 hasta (%3.1), TB ve 17 hasta sınıflanmayan hastalıklar (%6.1) olarak saptandı. Sonuç olarak, her kliniğin kendi mortalite oranlarını ve nedenlerini bilmesinin hasta yaklaşımı açısından yararlı olacağını ve eşlik eden hastalıkların dikkate alınmasının mortaliteyi azaltmada faydalı olacağını düşünmekteyiz.
FULL TEXT (PDF): 
PDF icon arastirmax-gogus-hastaliklari-kliniginde-mortalite-nedenleri.pdf
  • 2
42-45
  • Turkish

REFERENCES

References: 

1- Murray CJL, Lopez AD. Alternative projections of mortality and
disability by cause 1990-2020: global burden of disease study.
Lancet 1997;349:1498-504.
2- Çımrın A. Kronik obstrüktif akciğer hastalığında son dönem.
Umut S, Erdinç E (Editörler). Kronik obstrüktif akciğer
hastalığı. İstanbul: Turgut Yayıncılık; 2000:273-9.
3- Bilir N. Ulusal akciğer sağlığının temel göstergeleri ve
araştırma öncelikleri. Toraks Dergisi 2002; 3: 317-20
4- Toraks Derneği erişkin ve çocuklarda toplum kökenli pnömoni
tanı ve tedavi rehberi, 2002. Toraks Dergisi 2002;3(Ek 3):1-15.
5- Garibaldi RA. Epidemiology of community-acquired respiratory
tract infections in adults: incidence, etiology and impact. Am J
Med 1985;78 (Suppl 6B):32-7.
6- Baudouin SV. The pulmonary physician in critical care 3:
critical care management of community acquired pneumonia.
Thorax 2002;57:267-71.
7. Feldman C, Viljoen E, Morar R et al. Prognostic factors in
severe community- acquired pneumonia in patients without
co-morbid illness. Respirol 2001;6:323-30.
8- Torres A, Dorca J, Zalacain R et al. Community-acquired
pneumonia in chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 1996;154:1456-61.
9- Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes
of patients with community-acquired pneumonia. JAMA
1996;275:134-41.
10- Fidan A, Kıral K, Erdem İ ve ark. Toplum Kökenli Pnömonilerde
Hastane Mortalitesi ve Ulusal Pnömoni Tanı ve Tedavi
Rehberine Göre Değerlendirme Türk Toraks Dergisi Ağst 2005,
Cilt 6, Sayı 2, Sayfa(lar) 115-121
11- Busset AS. Risk factors for COPD. Eur Respir Rev 1996;6:253-58.
12- American Thoracic Society. Standards for the diagnosis and
care of patients with chronic obstructive pulmonary disease
(COPD). Am J Respir Crit Care Med 1995;152:77-120.
13- Barns PJ. Managing chronic obstructive pulmonary disease.
Londra: Science Press;2000
14- Siafakas NM, Bouros D. Management of acute exacerbation
of chronic obstructive pulmonary disease. In:Postma DS,
Siafahas NM; eds. Management of chronic obstructive
pulmonary disease. ERS Monograph. Sheffield: ERS Journal
Ltd Publication Office;998:264-77.
15- Aytemur Z, Göksel T, Baysak A ve ark Kronik Obstrüktif Akciğer
Hastalığı Ataklarında Mortalite: Toraks Dergisi 2002;3(1):22-25
16- Halilçolar H, Tatar D, Ertuğrul G ve ark. Akkoçlu A, Öztürk
C; (eds). Akciğer Kanseri: Multidisipliner Yaklaşım.Toraks
Kitapları 1999;1:17-22.
17- Kochi A. The global tuberculosis situation and the new control
strategy of the World Health Organisation.Tubercle 1991;72:
1-6.
18- Pengo V, Lensing AW, Prins MH, et al. Incidence of CTEPH
after pulmonary embolism. N Engl J Med 2004;35:2257-64.
19- Shigeta A, Tanabe N, Shimizu H, et al. Gender differences
in chronic thromboembolic pulmonary hypertension inJapans.
Circ J 2008;72:2069-74.
20- Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic
pulmonary hypertension Eur Respir J 2004;23:637-48.
21- Pengo V, Lensing AWA, Prins MH, et al. for the Thromboembolic
Pulmonary hypertension Study Group.Incidence of Chronic
Thromboembolic Pulmonary Hypertension after Pulmonary
Embolism. N Engl J Med 2004; 350: 2257-64.

Thank you for copying data from http://www.arastirmax.com